Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $15.3500 (-0.71%) ($14.6500 - $15.6200) on Tue. Jul. 7, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7% (three month average) | RSI | 86 | Latest Price | $15.3500(-0.71%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 2% a day on average for past five trading days. | Weekly Trend | ATRA advances 16.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) IWO(44%) ARKK(43%) | Factors Impacting ATRA price | ATRA will decline at least -3.5% in a week (0% probabilities). VIXM(-32%) VXX(-27%) XLC(-9%) UUP(-9%) TLT(-9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.5% (StdDev 7%) | Hourly BBV | 0 () | Intraday Trend | 0.7% | | | |
|
5 Day Moving Average | $15.02(2.2%) | 10 Day Moving Average | $14.22(7.95%) | 20 Day Moving Average | $12.38(23.99%) | To recent high | -0.7% | To recent low | 99.4% | Market Cap | $1.141b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |